Imarx Therapeutics, Inc.
12277 134th NE
Suite 202
Redmond,
WA 98052
Phone: 425-821-5501
Fax: 425-821-1404
Web Site: http://www.imarx.com
| REUTERS ABRIDGED BUSINESS SUMMARY | |
| ImaRx Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the development of therapies for stroke and other vascular disorders, using its microbubble technology. Its lead program, SonoLysis, involves the administration of its MRX-801 microspheres and ultrasound to break up blood clots and restore blood flow to oxygen deprived tissues. The company was founded in 1999 and is based in Redmond, Washington. |
|
| Key Statistics | |
| |
| | Pay | Exercised | Mr. Richard L. Love M.S., 66
Chairman, Principal Exec. Officer, Principal Financial Officer, Member of Compensation Committee and Member of Nominating & Corp. Governance Committee |
$
29.00K | N/A | Dr. Reena Zutshi Ph.D., 42
VP of Operations |
N/A
| N/A | Dr. Garen Manvelian M.D., 46
Chief Medical Officer and VP of Clinical Devel. |
N/A
| N/A | Mr. John McCambridge , 61
VP of Sales & Marketing |
N/A
| N/A | Ms. Jennifer Marshall , 46
VP of Corp. Devel. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
Profile
Help
